-
Product Insights
Likelihood of Approval Analysis for Post Partum Depression (Maternal Depression / Postnatal Depression)
Overview How likely is it that the drugs in Post Partum Depression (Maternal Depression / Postnatal Depression) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Post Partum Depression (Maternal Depression /...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – JBPOS-0101 in Post Partum Depression (Maternal Depression / Postnatal Depression)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - JBPOS-0101 in Post Partum Depression (Maternal Depression / Postnatal Depression) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JBPOS-0101 in Post Partum Depression (Maternal...
-
Product Insights
Post Partum Depression (Maternal Depression / Postnatal Depression) – Drugs In Development, 2023
Global Markets Direct’s, ‘Post Partum Depression (Maternal Depression / Postnatal Depression) - Drugs In Development, 2023’, provides an overview of the Post Partum Depression (Maternal Depression / Postnatal Depression) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Post Partum Depression (Maternal Depression / Postnatal Depression), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the...
-
Sector Analysis
NewPeru Statutory and Private Employee Benefits, 2024 Update
Peru Statutory and Private Employee Benefits Overview The social security system in Peru is undergoing significant change. The informal nature of the labor market is the reason for low social security contributions. Most workers are self-employed and there are lack of information and valuation within the system. In the early 1990s, the social security system established the Sistema Privado de Pensiones (private pension system, or SPP) to provide benefits in the event of old age, disability, and death. This was...
-
Sector Analysis
NewArgentina Statutory and Private Employee Benefits, 2024 Update
Argentina Statutory and Private Employee Benefits Overview The Argentina social security system is comprehensive covering a wide variety of benefits such as retirement, death in service, long-term disability, short-term sickness, medical, workers’ compensation insurance, and maternity and paternity benefits. Furthermore, in Argentina, employers offer additional benefits to their employees through a defined contribution pension system, group health insurance plans, group life insurance plans, and a group personal accident insurance plan. The defined contribution pension plans are not too prevalent in...
-
Sector Analysis
Slovakia Statutory and Private Employee Benefits, 2024 Update
Slovakia Statutory and Private Employee Benefits Overview Following independence in 1993, the Slovak government reformed taxation, healthcare, pensions, and the social welfare system. These reforms helped the government to consolidate the budget and move towards joining the EU in 2004. The country also introduced several investor-friendly policies – including labor market liberalization. The Slovakia employee benefits report provides in-depth industry analysis, information, and insights into employee benefits in Slovakia, including an overview of the state and compulsory benefits, detailed information...
-
Sector Analysis
Portugal Statutory and Private Employee Benefits, 2024 Update
Portugal Statutory and Private Employee Benefits Overview The Portuguese social security system is based on universality; it ensures that the social protection provided by the system is available for everyone. It consists of the Public Social Security System, the Social Action System, and the Supplementary System. The Family Support System, Welfare, and Solidarity subsystems comprise the Public Social Security System. The Portugal employee benefits report provides in-depth industry analysis, information, and insights into employee benefits in Portugal, including an overview...
-
Sector Analysis
Norway Statutory and Private Employee Benefits, 2024 Update
Norway Statutory and Private Employee Benefits Overview The Norwegian employee benefits market is predominantly controlled by the public social security system. However, the growth of labor-intensive industries has fuelled the growth of the country’s private benefits market over the last decade. In Norway, general social insurance schemes are provided to citizens through the public social security system, which is overseen by the Norwegian Labor and Welfare Administration (Arbeids- og velferdsetaten; NAV). This system is important to the welfare system of...
-
Sector Analysis
Russia Statutory and Private Employee Benefits, 2024 Update
Russia Statutory and Private Employee Benefits Overview Russia underwent major economic and political changes following the collapse of the Soviet Union in the 1990s. During this two-decade transition period, several changes were made to the country's social security system. The development of private employee benefit plans took place. A three-tier pension system was established. Cost-of-living compensation was set up. The current geopolitical situation in Russia is causing significant stress and anxiety for the Russian as well as MNCs’ employers. Companies...
-
Product Insights
Likelihood of Approval Analysis for Female Infertility
Overview How likely is it that the drugs in Female Infertility will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Female Infertility Overview Female infertility refers to infertility in women. Causes or...